PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
23-Sep-2020 Aqualung Therapeutics Corp. Awarded $300K from NIH to Develop A Novel Therapeutic For Pregn Aqualung Therapeutics
23-Sep-2020 Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020 Lynparza recommended for approval in EU by CHMP as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer AstraZeneca
23-Sep-2020 Lynparza recommended for approval in the EU by CHMP for BRCA-mutated metastatic castration-resistant prostate cancer AstraZeneca
23-Sep-2020 Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial AstraZeneca
23-Sep-2020 Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial Novo Nordisk
23-Sep-2020 Preliminary Results for the year ended 30 June 2020 Allergy Therapeutics plc
23-Sep-2020 PureTech Plans U.S. Listing on Nasdaq Global Market PureTech Health
23-Sep-2020 Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI) Helsinn
23-Sep-2020 UCB Achieves Important Regulatory Milestone for Bimekizumab UCB
23-Sep-2020 Thomas International launches new Talent Assessment Platform Thomas International
21-Sep-2020 UCB launches Community Health Fund to support vulnerable young people post-COVID-19 crisis UCB
21-Sep-2020 Vifor Pharma Group Announces Successful Sale of OM Pharma Vifor Pharma
21-Sep-2020 Lawrence Whittard Obituary: Founder of Cherwell Laboratories Cherwell Laboratories
21-Sep-2020 Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50% Sanofi
21-Sep-2020 ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP™ HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION Abbott
21-Sep-2020 Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020 Genmab
21-Sep-2020 Global Monoclonal Mouse Antibody Market| Top Key players: Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, and Seattle Genetics Lexis Business Insights
21-Sep-2020 Latest report: Global Neuropathy Pain Treatment Market| Pfizer, Depomed, Eli Lilly, Endo, Grünenthal Group, and Arbor Pharmaceuticals Lexis Business Insights
18-Sep-2020 Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020 Envision Pharma Group